Question

exam lesson name: introduction to biotechnology
exam number: (007040)
a. exam guidelines
b. exam instructions
question 14 of 20 :
select the best answer for the question.

1. which of the following information is given to participants in clinical trials as part of obtaining informed consent?

● a. possible side effects of a new medical treatment or product
● b. information on how to purchase the product or treatment through the participant’s insurance
● c. information on how to participate in future clinical trials
● d. an explanation of how the product or treatment was developed
● mark for review (will be highlighted on the review page)
● previous question ● next question >>

Explanation:

Informed consent in clinical trials requires disclosing risks, including possible side effects of the new medical treatment or product. Option B is about purchasing (not part of informed consent for trial participation). Option C is about future trials (not core to initial informed consent for the current trial). Option D is about development (not a key risk/information for participants to decide participation). So A is correct as side effects are critical info for informed consent.

Answer:

A. Possible side effects of a new medical treatment or product